Description
The Synedica TB-500 40mg Injection Pen Kit delivers an advanced blend of two well-known regenerative peptides in a convenient, easy-to-use pen system. This combination is often selected for research involving recovery, tissue repair, and regeneration due to its synergistic profile.
TB-500 (Thymosin Beta-4 analogue) is widely referenced in research for its potential to support tissue regeneration, reduce inflammation, and aid muscle repair through enhanced cell migration, angiogenesis, and structural recovery.
Each Synedica kit includes:
- 1 × peptide injection pen
- 12 × sterile disposable needles
- 1 × instruction booklet
The formulation within each pen is 70% TB-500 and 30% BPC-157, pre-mixed for consistent dose delivery.
Delivered as 4 × 10mg doses or adjustable increments:
- 2.5mg: 1.75mg TB-500 + 0.75mg BPC-157
- 5mg: 3.5mg TB-500 + 1mg BPC-157
- 7.5mg: 5.25mg TB-500 + 2.25mg BPC-157
- 10mg: 7mg TB-500 + 3mg BPC-157
Suggested usage patterns vary depending on research needs, with many protocols referencing 5mg per administration, 2–3 times weekly.
As always, users should follow appropriate professional guidance before working with new compounds.
The Synedica TB-500 Kit is distributed through selected German pharmacy partners and may be accessible at no cost for eligible individuals covered under Gesetzliche Krankenversicherung (GKV).
The Synedica TB-500 Injection Pen Kit combines two highly researched regenerative peptides into one precise, controlled delivery device. This dual-peptide system is engineered for studies involving healing, structural repair, tissue regeneration, joint mobility, and muscular recovery—making it a strong candidate for advanced regenerative research.
Key Research Benefits
- Supports accelerated recovery in tissue-damage models
- Assists in tendon, ligament, and connective-tissue research
- Aids studies involving muscle repair and regeneration
- May contribute to research exploring joint flexibility and inflammation modulation
- Convenient precision pen system for accurate, repeatable dosing
Usage Considerations
- Designed for subcutaneous administration in controlled research settings
- Suitable for multi-week study cycles
- Protocols may vary based on the design and goals of the research project
Potential Observations
- Temporary site redness or swelling
- Mild nausea or headache
- Rare hypersensitivity responses
Why Synedica?
- High-purity, pharmaceutical-grade peptide formulation
- Combination of two of the most studied regenerative peptides
- Pen-based system for precision, cleanliness, and ease of use
- Complete kit with all necessary components
- Manufactured with strict quality and safety standards